DK166825B1 - Antitumor-platinkomplekser og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse - Google Patents
Antitumor-platinkomplekser og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse Download PDFInfo
- Publication number
- DK166825B1 DK166825B1 DK426486A DK426486A DK166825B1 DK 166825 B1 DK166825 B1 DK 166825B1 DK 426486 A DK426486 A DK 426486A DK 426486 A DK426486 A DK 426486A DK 166825 B1 DK166825 B1 DK 166825B1
- Authority
- DK
- Denmark
- Prior art keywords
- platinum
- ion
- cis
- formula
- nitrate
- Prior art date
Links
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical class [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 title claims description 17
- 239000008177 pharmaceutical agent Substances 0.000 title claims description 3
- 230000000259 anti-tumor effect Effects 0.000 title abstract description 7
- 238000000034 method Methods 0.000 title description 15
- 150000001450 anions Chemical class 0.000 claims abstract description 21
- 150000001875 compounds Chemical class 0.000 claims description 67
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 229910002651 NO3 Inorganic materials 0.000 claims description 31
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 31
- -1 halide ion Chemical class 0.000 claims description 14
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 13
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 12
- 239000005977 Ethylene Substances 0.000 claims description 12
- HRGDZIGMBDGFTC-UHFFFAOYSA-N platinum(2+) Chemical compound [Pt+2] HRGDZIGMBDGFTC-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 10
- 229910052727 yttrium Inorganic materials 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 238000006396 nitration reaction Methods 0.000 claims description 7
- 229910052697 platinum Inorganic materials 0.000 claims description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 5
- 239000002246 antineoplastic agent Substances 0.000 claims description 5
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 claims description 5
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Chemical compound [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 claims description 5
- 230000019635 sulfation Effects 0.000 claims description 4
- 238000005670 sulfation reaction Methods 0.000 claims description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003446 ligand Substances 0.000 abstract description 13
- 150000003057 platinum Chemical class 0.000 abstract description 4
- 125000002947 alkylene group Chemical group 0.000 abstract description 3
- 125000004122 cyclic group Chemical group 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- SGLJYTWMWIAGEU-UHFFFAOYSA-N cyclohexane-1,2-diamine;platinum(2+) Chemical compound [Pt+2].NC1CCCCC1N SGLJYTWMWIAGEU-UHFFFAOYSA-N 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 239000007864 aqueous solution Substances 0.000 description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 17
- 239000000243 solution Substances 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 239000002244 precipitate Substances 0.000 description 14
- 239000000203 mixture Substances 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 9
- 229960004316 cisplatin Drugs 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 8
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 8
- 238000001914 filtration Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 description 6
- 239000002198 insoluble material Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- BHKICZDKIIDMNR-UHFFFAOYSA-L azane;cyclobutane-1,1-dicarboxylate;platinum(4+) Chemical compound N.N.[Pt+4].[O-]C(=O)C1(C([O-])=O)CCC1 BHKICZDKIIDMNR-UHFFFAOYSA-L 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 229960004562 carboplatin Drugs 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- YMHQVDAATAEZLO-UHFFFAOYSA-N cyclohexane-1,1-diamine Chemical compound NC1(N)CCCCC1 YMHQVDAATAEZLO-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 210000004881 tumor cell Anatomy 0.000 description 4
- ZMGMDXCADSRNCX-UHFFFAOYSA-N 5,6-dihydroxy-1,3-diazepan-2-one Chemical class OC1CNC(=O)NCC1O ZMGMDXCADSRNCX-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- SSJXIUAHEKJCMH-UHFFFAOYSA-N cyclohexane-1,2-diamine Chemical compound NC1CCCCC1N SSJXIUAHEKJCMH-UHFFFAOYSA-N 0.000 description 3
- 231100000417 nephrotoxicity Toxicity 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 229910001961 silver nitrate Inorganic materials 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229940045985 antineoplastic platinum compound Drugs 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 231100000171 higher toxicity Toxicity 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 150000003058 platinum compounds Chemical class 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- UUERTZXRKZEANK-UHFFFAOYSA-L (2-azanidylcyclohexyl)azanide;dichloroplatinum(2+) Chemical compound C1CCCC2N[Pt](Cl)(Cl)NC21 UUERTZXRKZEANK-UHFFFAOYSA-L 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- NQPJDJVGBDHCAD-UHFFFAOYSA-N 1,3-diazinan-2-one Chemical compound OC1=NCCCN1 NQPJDJVGBDHCAD-UHFFFAOYSA-N 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 101100522123 Caenorhabditis elegans ptc-1 gene Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 208000007093 Leukemia L1210 Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100509103 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ish1 gene Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- JKNZUZCGFROMAZ-UHFFFAOYSA-L [Ag+2].[O-]S([O-])(=O)=O Chemical compound [Ag+2].[O-]S([O-])(=O)=O JKNZUZCGFROMAZ-UHFFFAOYSA-L 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000001118 alkylidene group Chemical group 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000003327 cancerostatic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- UQKCTBFPACVZSU-UHFFFAOYSA-N cyclohexane-1,2-diamine;platinum(2+);dinitrate Chemical compound [Pt+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O.NC1CCCCC1N UQKCTBFPACVZSU-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910001412 inorganic anion Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 1
- 229910000367 silver sulfate Inorganic materials 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- APPUVMLQTFWVKR-UHFFFAOYSA-N uranium(5+) Chemical compound [U+5] APPUVMLQTFWVKR-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F17/00—Metallocenes
- C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19709785 | 1985-09-06 | ||
| JP19709785 | 1985-09-06 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK426486D0 DK426486D0 (da) | 1986-09-05 |
| DK426486A DK426486A (da) | 1987-03-07 |
| DK166825B1 true DK166825B1 (da) | 1993-07-19 |
Family
ID=16368672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK426486A DK166825B1 (da) | 1985-09-06 | 1986-09-05 | Antitumor-platinkomplekser og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0214862B1 (de) |
| JP (1) | JPH0655752B2 (de) |
| KR (1) | KR890004351B1 (de) |
| CN (1) | CN1016345B (de) |
| AT (1) | ATE61560T1 (de) |
| AU (1) | AU581101B2 (de) |
| CA (1) | CA1281327C (de) |
| DE (1) | DE3678070D1 (de) |
| DK (1) | DK166825B1 (de) |
| ES (1) | ES2001669A6 (de) |
| FI (1) | FI83086C (de) |
| HU (1) | HU196606B (de) |
| NO (1) | NO172184C (de) |
| PH (1) | PH25038A (de) |
| SU (1) | SU1565347A3 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0665648B2 (ja) * | 1985-09-25 | 1994-08-24 | 塩野義製薬株式会社 | 白金系抗癌物質の安定な凍結真空乾燥製剤 |
| DK252688A (da) * | 1987-05-08 | 1988-11-09 | Sankyo Co | Antitumorplatinkomplekser, fremgangsmaade til fremstilling deraf, samt deres terapeutiske anvendelse |
| EP0897389B1 (de) * | 1996-03-11 | 2002-07-03 | Yoshinori Kidani | Binukleare platinkomplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese komplexe enthalten |
| ITMI991508A1 (it) | 1999-07-09 | 2001-01-09 | Novuspharma Spa | Nitrati di bis-platino complessi con ligandi poliamminici |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4207416A (en) * | 1974-09-05 | 1980-06-10 | Engelhard Minerals & Chemicals Corporation | Ethylenediamineplatinum(II) 2,4-dioxopyrimidine complexes |
| CH617587A5 (de) * | 1974-09-05 | 1980-06-13 | Engelhard Min & Chem | |
| US4419351A (en) * | 1977-06-03 | 1983-12-06 | Research Corporation | Platinum-dioxopyrimidine complexes |
-
1986
- 1986-09-05 DK DK426486A patent/DK166825B1/da not_active IP Right Cessation
- 1986-09-05 JP JP61209014A patent/JPH0655752B2/ja not_active Expired - Fee Related
- 1986-09-05 PH PH34223A patent/PH25038A/en unknown
- 1986-09-05 FI FI863599A patent/FI83086C/fi not_active IP Right Cessation
- 1986-09-05 SU SU864028205A patent/SU1565347A3/ru active
- 1986-09-05 AU AU62415/86A patent/AU581101B2/en not_active Ceased
- 1986-09-05 NO NO863553A patent/NO172184C/no unknown
- 1986-09-05 ES ES8601700A patent/ES2001669A6/es not_active Expired
- 1986-09-05 HU HU863866A patent/HU196606B/hu not_active IP Right Cessation
- 1986-09-06 CN CN86106751A patent/CN1016345B/zh not_active Expired
- 1986-09-06 KR KR1019860007459A patent/KR890004351B1/ko not_active IP Right Cessation
- 1986-09-08 DE DE8686306914T patent/DE3678070D1/de not_active Expired - Fee Related
- 1986-09-08 CA CA000517690A patent/CA1281327C/en not_active Expired - Fee Related
- 1986-09-08 EP EP86306914A patent/EP0214862B1/de not_active Expired - Lifetime
- 1986-09-08 AT AT86306914T patent/ATE61560T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PH25038A (en) | 1991-01-28 |
| HU196606B (en) | 1988-12-28 |
| EP0214862B1 (de) | 1991-03-13 |
| JPS62149692A (ja) | 1987-07-03 |
| EP0214862A3 (en) | 1987-12-09 |
| KR890004351B1 (ko) | 1989-10-31 |
| NO863553L (no) | 1987-03-09 |
| DK426486D0 (da) | 1986-09-05 |
| FI83086C (fi) | 1991-05-27 |
| AU6241586A (en) | 1987-03-12 |
| NO863553D0 (no) | 1986-09-05 |
| FI83086B (fi) | 1991-02-15 |
| CN86106751A (zh) | 1987-03-25 |
| AU581101B2 (en) | 1989-02-09 |
| NO172184C (no) | 1993-06-16 |
| CA1281327C (en) | 1991-03-12 |
| FI863599A0 (fi) | 1986-09-05 |
| DK426486A (da) | 1987-03-07 |
| JPH0655752B2 (ja) | 1994-07-27 |
| HUT41808A (en) | 1987-05-28 |
| CN1016345B (zh) | 1992-04-22 |
| FI863599A (fi) | 1987-03-07 |
| SU1565347A3 (ru) | 1990-05-15 |
| KR870003129A (ko) | 1987-04-15 |
| EP0214862A2 (de) | 1987-03-18 |
| ATE61560T1 (de) | 1991-03-15 |
| DE3678070D1 (de) | 1991-04-18 |
| NO172184B (no) | 1993-03-08 |
| ES2001669A6 (es) | 1988-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0155705B1 (de) | Antitumor-Platin-Komplexe | |
| Hoeschele et al. | Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum (II) chelate complexes incorporating the cis-1, 4-diaminocyclohexane ligand in a unique locked boat conformation | |
| CA2370692C (en) | Antitumor derivative of double dicarboxylic acid diaminoplatin complex, process for the preparing thereof, the pharmaceutical composition containing the same and application of the derivative | |
| CN102286050A (zh) | 用于肿瘤靶向治疗的含葡萄糖铂配合物及其制备方法 | |
| CN102716146A (zh) | 水溶性铂配合物在制备防治肿瘤药物的用途 | |
| FI76351C (fi) | Foerfarande foer framstaellning av 2,2-substituerade 1,3-alkandiaminplatina(ii)komplexer med antitumoeraktivitet. | |
| FI116058B (fi) | Kolme ydintä käsittävät kationiset platinakompleksit, joilla on kasvaimenvastainen vaikutus, sekä niitä sisältävät farmaseuttiset koostumukset | |
| DK166825B1 (da) | Antitumor-platinkomplekser og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
| CA1186307A (en) | Glycolic acid platinum complexes | |
| EP1294732B1 (de) | Ruthenium (ii) verbindungen in der krebsbehandlung | |
| US5028727A (en) | Platinum-(IV)-diamine complex | |
| WO2004099224A1 (de) | Carboplatin-artige platin (ii)- komplexe | |
| JPH03151396A (ja) | 強い抗腫瘍活性を有する水及び溶媒に可溶なアキシャルヒドロキシ及びモノ及びジカルボン酸誘導体 | |
| EP0304566A2 (de) | Wasserlösliche Platinkomplexe von Malonsäure-Derivaten | |
| JP5284286B2 (ja) | ビス−ニトリル含有リガンドを有する白金類似体 | |
| EP0232784B1 (de) | (Gem-heterocyclodimethanamin-N,N')platin Komplexe | |
| RU2033998C1 (ru) | Комплексное соединение цис-диаминоплатины (ii) с сополимером na-соли малеиновой кислоты и фурана, обладающее иммуностимулирующей и противоопухолевой активностью, с широким интервалом терапевтических доз при низкой нефротоксичности | |
| RU2034856C1 (ru) | Комплексное соединение цис-диамминоплатины (п) с сополимером na-соли малеиновой кислоты и 1,4-диизопропоксибутена-2, обладающее противоопухолевой активностью с широким интервалом терапевтических доз при полном отсутствии нефротоксичности и иммунодепрессантного действия | |
| JPH03500532A (ja) | 白金系医薬品 | |
| CN106608898A (zh) | 含脱氧葡萄糖水溶性铂配合物及制备方法及用途 | |
| JPS6176497A (ja) | 白金錯体 | |
| CA2737683A1 (en) | Platinum complex with antitumor activity | |
| JPS6230792A (ja) | 新規白金錯体 | |
| DE10351021A1 (de) | Carboplatin-artige Platin (II)-Komplexe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PBP | Patent lapsed |